Axogen AXGN
NASDAQ AXGN
$47.27 +0.58 (+1.24%)
As of: Sep 9, 2026 · 3:59 PM EDT

Axogen (AXGN) Cash from Investing Activities (2010 - 2026)

Axogen (AXGN) posted Cash from Investing Activities of $500000.0 for Q2 2026, up 103.13% on a QoQ basis from -$16.0 million in Q1 2026, and up 107.2% year-over-year from $241315.8 in Q2 2025.

Analysis

Axogen (AXGN) Cash from Investing Activities (2010 - 2026) Analysis & Trends

Axogen has reported Cash from Investing Activities for 17 years, with the latest figure at $500000.0 in Q2 2026.

  • On a quarterly basis, Cash from Investing Activities rose 107.2% year-over-year to $500000.0 in Q2 2026; TTM through Jun 2026 was -$15.2 million, a 32.85% decrease from a year earlier, with the FY2025 full-year figure at -$5.3 million, up 48.36% from the prior year.
  • Cash from Investing Activities was $500000.0 for Q2 2026 at Axogen, up from -$16.0 million in the prior quarter.
  • The five-year high for Cash from Investing Activities was $14.3 million in Q2 2023, with the low at -$16.0 million in Q1 2026.
  • Average Cash from Investing Activities over 5 years is -$834722.2, with a median of -$799500.0 recorded in 2023.
  • The sharpest annual moves came in 2025 and 2026: Cash from Investing Activities surged 597.17% in 2025, then plunged 1292.23% in 2026.
  • Over 5 years, Cash from Investing Activities stood at -$1.2 million in 2022, then surged by 77.09% to -$277000.0 in 2023, then plunged by 193.5% to -$813000.0 in 2024, then soared by 597.17% to $4.0 million in 2025, then plunged by 87.63% to $500000.0 in 2026.
  • The last three Cash from Investing Activities figures came in at $500000.0 (Q2 2026), -$16.0 million (Q1 2026), and $4.0 million (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Investing Activities (Qtr)
1 Abbott Laboratories 187.42 Bn 182.47 Bn 7.27 Bn -673.00 Mn
2 Intuitive Surgical 129.78 Bn 124.69 Bn 1.96 Bn -26.60 Mn
3 Medtronic 120.53 Bn 112.33 Bn 6.34 Bn -1.62 Bn
4 Stryker 116.28 Bn 112.80 Bn 4.50 Bn -639.00 Mn
5 Boston Scientific 69.29 Bn 68.99 Bn 3.85 Bn -1.96 Bn
6 Edwards Lifesciences 51.83 Bn 47.68 Bn 1.35 Bn -193.20 Mn
7 Alcon 34.36 Bn 32.91 Bn 1.68 Bn -222.00 Mn
8 Dexcom 33.17 Bn 31.23 Bn 830.00 Mn 329.80 Mn
9 Steris 21.90 Bn 21.43 Bn 684.20 Mn -108.50 Mn
10 Axogen 2.59 Bn 2.48 Bn 50.67 Mn 500,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 500,000.00
Mar 31, 2026 -15.96 Mn
Dec 31, 2025 4.04 Mn
Sep 30, 2025 -3.75 Mn
Jun 30, 2025 -6.95 Mn
Mar 31, 2025 1.34 Mn
Dec 31, 2024 -813,000.00
Sep 30, 2024 -5.00 Mn
Jun 30, 2024 -1.23 Mn
Mar 31, 2024 -3.25 Mn
Dec 31, 2023 -277,000.00
Sep 30, 2023 5.99 Mn
Jun 30, 2023 14.32 Mn
Mar 31, 2023 -786,000.00
Dec 31, 2022 -1.21 Mn
Sep 30, 2022 2.97 Mn
Jun 30, 2022 2.28 Mn
Mar 31, 2022 -7.24 Mn
Dec 31, 2021 -13.59 Mn
Sep 30, 2021 -6.78 Mn